Clinical Proof of Concept of OVX836, a single-shot broadly protective Influenza A vaccine for immediate protection against emerging pandemic strains
This federal contract opportunity has been awarded to on July 25, 2025.
Award Information
This solicitation resulted in an award to for approximately $98,593,151 on July 25, 2025. Similar contracts are typically issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF under 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
- Award Number
- 75A50125C00008
- Award Amount
- $98,593,151
- Award Date
- July 25, 2025
Key Takeaways
- No response deadline specified - contact the agency for details
- Set-aside for No Set Aside businesses
- Work to be performed in Washington, DC
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- 75A50125C00008
- Opportunity Type
- Award Notice
- Sub-Agency
- OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
- Office
- ASPR ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
- Posted Date
- Tuesday, October 14, 2025
- Response Deadline
- Not specified
- PSC Code
- AN11
- Set-Aside
- No Set Aside
- Place of Performance
- Washington, DC, 20201
- Status
- Active
Description
No description available. View the full opportunity on SAM.gov for complete details.
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in Washington, DC. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
